Article
Guidelines on the Diagnosis, Clinical Assessments, Treatment and Management for CLN2 Disease Patients
2020-10-28
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2), or Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL), is an ultra-rare, neurodegenerative lysosomal storage disease, caused by an enzyme deficiency of tripeptidyl peptidase 1 (TPP1). Lack of disease awareness and the non-specificity of presenting symptoms often leads to delayed diagnosis. These guidelines...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c14d19f7-bc98-50f1-be25-89bc9519c805
- DOI
- 10.21203/rs.3.rs-96773/v1
